studied in rats. The general pattern was similar to mice; less radioactivity was found in brain after administration of the ring-labeled alkaloid than after administration of methoxy-labeled colchicine. Again, 40-50% of ring-labelled colchicine was precipitated by vinblastine. These experiments, together with behavioral experiments (6) , support the hypotheses that structural alterations in synapses by recently synthesized proteins which are transported down the axons and dendrites may be an essential process for long-term memory formation.
INTRODUCTION
Substantial evidence has been obtained that protein synthesis is essential for long-term memory formation (for reviews see 5, 7) . It has been suggested by CronlY-Dillon et.tl. (3) that microtubules may be involved in fast transport of the necessary neurochemical s from the cell body to th-e synaptic endings to bring about the local changes in membrane structure or cell morphology that result from learning and which are presumed necessary to , establish long-term memory. CronlY-Dillon et.tl. showed that colchicine administered intracranially to goldfish impaired long-term memory formation.
Crothers and McCluer demonstrated that intracranially administered colchicine impaired the axoplasmic transport of proteins in mice (4) . The behavioral experiments, reported by Flood et.tl. in a companion paper (6) to this, were initiated after Rose and Sinha (14)'reported that colchicine administered intraperitoneally to rats at a dose of 40 ~g/kg impaired the accumulation of radioactively-labeled protein into synaptosomes.
The initial purpose of the biochemical experiments reported here was to estimate the amount of colchicine entering the mouse brain after its subcutaneous administration under the conditions of the behavioral experiments described by Flood et.tl. (6) . During the course of these experiments, it became apparent that significantly less radioactivity entered the mouse brain than had been anticipated based upon the reports of Stewart and Rose (18) from experiments using rats. Subsequent experiments were then performed in rats, mice, and chicks to compare the effects of (a) label position and (b) species upon apparent uptake of colchicine. In addition, the tubulin content of mouse brain was determined by colchicine binding assays, and the ratio of colchicine uptake to tubulin was estimated. While only a small quantity of colchicine enters the brain of mice or rats, the amounts are comparable with the dose shown to be behaviorally effective. (6) . Breeding Lab were used. Animals were maintained on a 12 hr light-12 hr dark cycle and were housed singly for 2-3 days prior to the experiment.
GENERAL DESCRIPTION OF PROCEDURE
Fertilized White Leghorn chicken eggs were obtained from a local hatchery, and the chicks were hatched in the laboratory and were maintained in the incubator room at 37°C until sacrificed.
[Ring A-4-3 H] colchicine (in ethanol) was obtained from Amersham Corp.
The specific activity of the three batches used in these experiments was 7.7
Ci/mmole. The colchicine was stored in the dark at -10°C and 'appeared to be 
EXPERIMENTAL PROCEDURE
To conform to the drug design used in the behavioral studies (6), ANI was administered subcutaneously to mice at a dosage of 20 mg/kg in Experiments 3-10. Seventy-five min later, radioactive colchicine was administered subcutaneously in 0.3 ml of 0.9% NaCl. In subsequent experiments, ANI was not administered; results were unchanged. The mice were anesthesized by ether; a ~lood sample was taken, and then the animal was perfused with normal saline prior to dissection of liver and brain. These two organs were weighed. Typically, two brains (0.4-0.5 g each) were combined and homogenized in 1.0 ml of PMG buffer (10 mM sodium phosphate with 0.1 mM GTP and 5 mM MgC1 2 , pH 6.8) (16). The homogenate was centrifuged for 30 min at 20,000 RPM (50,000 x g) at 4°C in a Sorvall RC2B centrifuge, SM-24 head.
The precipitate was resuspended in 1.0 ~l PMG buffer, recentrifuged, and the supernatants combined (Sl)' The combined volume of S1 was typically 1.6-1. The biochemical procedures used for the rat experiments were similar to those used for mice, except that one rat was used for each experiment, no ANI was given; and colchicine was injected intraperitonally rather than were analyzed by the same biochemical procedure as described for mouse brains.
Livers were homogenized at a concentration of 100 mg/ml in H 2 0; 100 ~l aliquots were counted in a gelled scintillator solution without further processing. Blood samples (10 ~l) were also directly counted; it was assumed that the total blood volume of a mouse is 78 ml/kg (21), a rat 58 ml/kg (8) and chick 2.0 ml.
.-6 Tubulin Content of Brain
The tubulin content of mouse brain was determined by gel filtration following described procedures (16,20). The 50,000 x g 51 supernatant was prepared as described above using homogenate concentrations ranging from 0.05 g brain/ml to 0.5 g/ml. The supernatant was incubated at 37°C for 60 min with 50 x 10-6 M colchicine, sp. act. 88,000dpm/nM. One ml of this incubation mixture was chromatographed thru a 5ephadex G100 column, 1 x 9 cm, using 10 mM sodium phosphate-10 mM MgC1 2 buffer, pH 6.8. One ml aliquots were collected. Total radioactivity, vinblastine-precipitable radioactivity, and total protein (determined by the Lowry procedure with bovine serum albumin as standard), were determined on aliquots.
Determination of Radioactivity
Radioactivity was determined with a Packard Model 3385 scintillation counter using mini-vials. Counting efficiency, typically 30-40%, was determined from the AE5 ratio and checked by internal standards. The counting mixture normally contained 100-500 ~l of sample, 1.2 ml of H 2 0, and 3 ml of rpi complete counting cocktail 3a70B.
In each experiment, the corresponding tissue from a pair of mice, a.rat, or a chick which had not been injected with radioactive colchicine was fractionated by the described procedure, and appropriate aliquots were used for background corrections. This was particularly important for brain samples, especially those from rat, since total counts were low and the blank correction was a significant fraction of the total counts.
RESULTS
The main objective of the first series of experiments was to determine the amount of colchicine entering mouse brain under the conditions of our behavioral experiments. A dose of about 4 nM/mouse was chosen because this approximated the behaviorally effective dose. Mice were sacrificed 3 hr.
after administration of ring-[3H]-labeled colchicine since the behavioral experiments suggested that this period was critical for determining long-term memory formation in these experiments. The mice were administered ANI, but other experiments indicated that ANI had little effect on the uptake of ring-labeled colchicine.
The results, summarized in Table 1 , showed"that while substantial quantities of radioactivity were present in liver~ and moderate quantities in blood, less than 0.01% of the administered radioactivity (0.4 picomoles equivalent colchicine) was found in brain. About 60% of this radioactivity was found in the S1 supernatant, and 40% remained in the once-washed precipitate.
Approximately 40% of the radioactivity, equivalent to 0.14 pm of colchicine, was precipitated with tubulin by 2 x 10-3 M vinblastine.
Approximately an equivalent amount of radioactivity (40-50%) was found in samples of brain supernatant dried in an N 2 -stream. Little or no radioactivity was precipitated by 6% trichloracetic acid (Note that 4% of the brain supernatant activity is equivalent to about 200 dpm after administration of 30 vei of colchicine). Little radioactivity is lost from brain between 3 and 24 hrs after administration of labeled colchicine (Tables   1 and 2 ).
In light of the report (18), indicating that much larger amounts of colchicine were found in rat brain after its administration, subsequent experiments were designed to resolve the discrepancies between that report and our results. In the first of these experiments [ring C-methoxy_3H] colchicine was used instead of ring A-lab~led colchicine. Using [ring C-methoxy_3H] colchicine, the proportions of the injected radioactivity retained in blood, liver, and brain of mice were all much higher than had been found with ring A-labeled colchicine (Table 2 ). However, the proportion where the dosage was increased by a factor of 8 to 12, showed that the uptake in brain was not saturated over this dose range, but was, instead, proportional to dose. Again, in contrast to the report of Stewart and Rose (18) essentially none of the radioactivity was precipitable by TCA.
The next series of experiments compared the uptake of both ring and methoxY-labeled colchicine in the rat at several time intervals (Table   3) . Even a smaller proportion of the injected radioactivity was found in rat brain by 3 hr after administration than had been found with mice.
Little, if any, of the radioactivity was precipitable by trichloroacetic acid. As with the mouse, more radioactivity was found in brain after the administration of methoxy-labeled colchicine than after the administration of ring-labeled material. Again, a smaller proportion of the methoxy-labeled drug was precipitated by vinblastine in the tubulin fraction than when ring ", .
A-labeled material was used. In rat, the sma1.1 amount of vinblastineprecipitable colchicine found in brain at any time precluded a determination of the time dependence of uptake.
The tubulin content of mouse brain was estimated to be a minimum of 3. provide data concerning colchicine uptake into the young chick brain. In spite of administration directly into (or near) the heart, and the young age of the chick, the amount present in brain (Table 4) colchicine, 120 ~Ci of colchicine was administered and typically less than 8,000 dpm was found in the brain homogenate. In experiment 1 R, 1.1 nM (8 ~Ci) of ring-labelled colchicine was administered, and less than 2000 dpm was detected in the brain. It thus appears unlikely that the low percentage uptake in our experiments is due to saturation. However, the apparent ~ptake of colchicine was somewhat influenced by the label position; again, more uptake was found when the methoxy-label colchicine was used. Up to 20 times as much radioactivity was found in mouse brain after administration of methoxy-labeled colchicine than after administration of ring-labeled drug.
Schtinharting, et AL. Am signifies Amersham was the supplier. 60%-70% of the radioactivity in brain was precipitated by vinblastine or co-chromatographed with tubu1in peak on a G-100 Sephadex column. These values were measured on the approximately 50% of the radioactivity in brain that extracted into S1 by our procedures.
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